Highlights Wayland Group Corp.

Equities

MRRCF

CA9442041062

Market Closed - OTC Markets Other stock markets 02:11:35 2024-05-16 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2021	RG5 Investments Inc. and Albert Sheeler cancelled the acquisition of Gardina Pharmaceutical SAS from Wayland Group Corp..	CI
2020	Wayland Group Corp. Announces Board and CEO Resignation	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RG5 Investments Inc. and Albert Sheeler cancelled the acquisition of Gardina Pharmaceutical SAS from Wayland Group Corp..	21-02-01	CI
CanAdelaar B.V. completed the acquisition of Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc.	20-04-22	CI
CanAdelaar B.V. agreed to acquire Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc. for CAD 12.4 million.	20-04-08	CI
RG5 Investments Inc. and Albert Sheeler agreed to acquire Gardina Pharmaceutical SAS from Wayland Group Corp. for CAD 0.3 million.	20-02-12	CI
Wayland Group cancelled the acquisition of 97% stake in Agro Ivica Dumandzic S.R.L.	19-12-09	CI
Maricann Group Inc. cancelled the acquisition of 51% stake in Theros Pharma Ltd.	19-12-04	CI
Wayland Group Corp. cancelled the acquisition of 50.1% stake in Tropicana Pty Ltd.	19-12-02	CI
ICC International Cannabis Corp. (CNSX:WRLD.U) cancelled the acquisition of 49.9% stake in Maricann B.V. from Wayland Group Corp..	19-11-12	CI
Maricann Group Inc. cancelled the acquisition of Colma Pharmaceutical SAS on November 6, 2019.	19-11-05	CI
Wayland Group Corp. Provides Corporate Update on Transaction, Construction and Operational Progress; Revises Revenue Guidance for 2019; Plans to Plan New Plants	19-10-31	CI
Wayland Group Announces its Selection as One of Three Groups, Pending Review Period, for Cannabis Production Licenses in Germany	19-04-04	CI
Wayland Group Corp. Provides Corporate Update on its Operational Progress in Canada and Internationally; Provides Revenue Guidance for the First Quarter, Second Quarter, Third Quarter and Fourth Quarter of 2019	19-02-20	CI
Wayland Group Receives EU-GMP Certification for German Facility	19-02-07	CI
International Cannabis and Wayland to Begin Integration of European Extraction and Distillation Processes	19-01-21	CI
ICC International Cannabis Corp. (CNSX:WRLD.U) entered into a letter of intent to acquire 49.9% stake in Maricann B.V. from Wayland Group Corp. for approximately CAD 150 million.	19-01-14	CI
Wayland Group entered into an agreement to acquire 97% stake in Agro Ivica Dumandzic S.R.L. for $7.4 million.	18-12-10	CI
Maricann Group Inc. agreed to acquire 50.1% stake in Tropicann Pty Ltd. for CAD 28.8 million.	18-12-02	CI
Maricann Group Inc. entered into an agreement to acquire 51% stake in Theros Pharma Ltd for £27.8 million.	18-11-25	CI
Wayland Group Announces Definitive Agreement for Italian Joint Venture with CBD Italian Factory S.S; Announces Massimiliano Umberto Signorini Assumes the Role of CEO	18-11-09	CI
Maricann Group Inc. agreed to acquire Colma Pharmaceutical SAS for 16.5 million.	18-11-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Wayland Group Corp.

Equities

MRRCF

CA9442041062

Highlights

Filters